|国家科技期刊平台
首页|期刊导航|中国实用神经疾病杂志|纤维化指标与急性缺血性脑卒中患者血管内治疗后症状性颅内出血风险的相关性

纤维化指标与急性缺血性脑卒中患者血管内治疗后症状性颅内出血风险的相关性OACSTPCD

Correlation between fibrosis indicators and the risk of symptomatic intracranial hemorrhage after endovascular treatment in patients with acute ischemic stroke

中文摘要英文摘要

目的 探讨纤维化指标与急性缺血性脑卒中(AIS)患者血管内治疗(EVT)后症状性颅内出血(sICH)风险的相关性.方法 回顾性纳入2018-03-2023-04于东南大学附属中大医院接受EVT治疗的358例AIS患者,入院24h内收集患者的年龄、性别、体重指数(BMI)、血压、既往史等人口统计资料,闭塞部位、卒中程度、FIB-4指数、EVT相关信息及术后sICH情况等临床资料,采用多因素Logistic回归分析FIB-4指数与EVT后sICH的相关性.结果 根据FIB-4临界值1.30与2.67,将患者分为FIB-4<1.30组(n=138)、FIB-4 1.30~2.67组(n=149)以及FIB-4>2.67组(n=71),3组性别、年龄、BMI、收缩压、糖尿病、高血压、高脂血症、大血管闭塞、术后sICH、90 d神经功能预后及基线NIHSS评分对比差异均有统计学意义(P<0.05).术后未发生与发生sICH患者的高脂血症、FIB-4评分、FIB-4<1.30及FIB-4>2.67对比差异均有统计学意义(P<0.05).90 d神经功能预后良好与不良患者的年龄、糖尿病、基线NIHSS评分、FIB-4评分、FIB-4<1.30及FIB-4>2.67对比差异均有统计学意义(P<0.05).术后sICH的多因素Logistic回归分析显示,高脂血症的OR=4.552,P=0.046,95%CI:1.030~20.108,FIB-4>2.67 的OR=0.078,P=0.001,95%CI:0.017~0.364,即高脂血症与FIB-4>2.67为AIS患者EVT术后sICH的影响因素.90 d神经功能预后的多因素Logistic回归分析显示,年龄的OR=1.220,P<0.001,95%CI:1.155~1.288,糖尿病的OR=0.763,P=0.037,95%CI:0.418~1.391,基线NIHSS评分的OR=1.121,P<0.001,95%CI:1.061~1.185,FIB-4>2.67的OR=0.603,P=0.107,95%CI:0.325~1.117,即年龄、糖尿病、基线NIHSS评分为AIS患者EVT术后90d神经功能预后的影响因素.结论 FIB-4指数与AIS患者EVT术后sICH风险相关,可作为sICH的独立预测因子,具有较高成本效益和预测准确性的参数,但不可作为90d神经功能预后的独立预测因子,有待前瞻性多中心研究进一步验证.

Objective To investigate the correlation between fibrosis indicators and the risk of symptomatic intracranial hemorrhage(sICH)after endovascular treatment(EVT)in patients with acute ischemic stroke(AIS).Methods A retrospective study was conducted on 358 AIS patients who received EVT treatment in the Zhongda Hospital Affiliated to Southeast University from March 2018 to April 2023.Within 24 hours of admission,demographic data such as age,gender,body mass index(BMI),blood pressure,past history,occlusive site,stroke severity,FIB-4 index,EVT related information,and postoperative sICH status were collected.The correlation between FIB-4 index and sICH after EVT was analyzed by multivariate Logistic regression.Results According to the critical value of FIB-4 1.30 and 2.67,the patients were divided into three groups:FIB-4<1.30(n=138),FIB-4 1.30-2.67(n=149)and FIB-4>2.67(n=71).There were significant differences in gender,age,BMI,systolic blood pressure,diabetes,hypertension,hyperlipidemia,large vessel occlusion,postoperative sICH,90-day neurological function prognosis and baseline NIHSS score(P<0.05).There were statistically significant differences in hyperlipidemia,FIB-4 score,FIB-4<1.30,and FIB-4>2.67 between patients without and with sICH after surgery(P<0.05).There were statistically significant differences in patients with good neurological function prognosis at 90-day and those with poor neurological function in terms of age,diabetes,baseline NIHSS score,FIB-4 score,FIB-4<1.30 and FIB-4>2.67(P<0.05).The results of multivariate Logistic regression analysis of postoperative sICH showed that hyperlipidemia(OR=4.552,P=0.046,95%CI:1.030-20.108),FIB-4>2.67(OR=0.078,P= 0.001,95%CI:0.017-0.364)were the influencing factors for postoperative sICH in AIS patients undergoing EVT.Multivariate Logistic regression analysis of 90-day neurological prognosis showed that age(OR=1.220,P<0.001,95%CI:1.155-1.288),diabetes(OR=0.763,P=0.037,95%CI:0.418-1.391),baseline NIHSS score(OR=1.121,P<0.001,95%CI:1.061-1.185),FIB-4>2.67(OR=0.603,P=0.107,95%CI:0.325-1.117)were prognostic factors for neurological function in AIS patients 90-day after EVT.Conclusion The FIB-4 index is associated with the risk of sICH after EVT in AIS patients,and can serve as an independent predictor of symptomatic intracranial hemorrhage.It has high cost-effectiveness and predictive accuracy as a parameter,but it cannot be used as an independent predictor of 90-day neurological function prognosis,the relevant data needs to be further validated in prospective multicenter studies.

陆悌明;任玲;张少轲

东南大学附属中大医院江北院区,江苏 南京 210000

临床医学

急性缺血性脑卒中血管内治疗症状性颅内出血高脂血症FIB-4指数神经功能预后

Acute ischemic strokeEndovascular treatmentSymptomatic intracranial hemorrhageHyperlipidemiaFIB-4 indexNeurological function prognosis

《中国实用神经疾病杂志》 2024 (003)

288-293 / 6

10.12083/SYSJ.230848

评论